New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
Our commitment to patient care and health is priority one here at Duren Apothecary.
We believe in the value of providing personalized service and quality products.
2024 © All Rights Reserved. Privacy Policy